相关实验视频

Updated: Jun 27, 2025

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

化疗诱导心脏毒性的生物标志物:使用细胞外囊泡进行精确预防

Brian B Silver^1,2, Anna Kreutz^1,3,4, Madeleine Weick²

¹Mechanistic Toxicology Branch, Division of Translational Toxicology (DTT), National Institute of Environmental Health Sciences (NIEHS), Durham, NC, United States.

Frontiers in oncology

|May 6, 2024

概括

细胞外囊泡 (EVs) 是化学疗法诱导心脏毒性的生物标志物,也是心脏保护剂. 需要进一步的研究,以了解复杂的EV信号,以获得更安全的癌症治疗.

科学领域:

心血管毒理学心血管毒理学
癌症治疗方法癌症治疗方法
蜂通信蜂通信

背景情况:

像多克索鲁比这样的化疗药物可以引起心脏毒性,限制癌症治疗的疗效.
细胞外囊泡 (EVs) 对于细胞通信至关重要,并且正在作为生物标志物和治疗药物进行探索.
电动汽车在心脏毒性中介导保护性和毒性信号的作用是复杂的,并未完全理解.

研究的目的:

探索细胞外囊泡 (EV) 作为缓解化疗诱导心脏毒性的临床工具的潜力.
讨论EVs作为预测心脏毒性和心脏保护性治疗剂的生物标志物.
解决治疗应用中异质EV混合物和有毒物质暴露的复杂性.

主要方法:

这项研究提供了对EVs在心脏毒性管理中的当前理解和未来前景的视角.
它回顾了化学疗法的背景下关于EV生物发生,货物和信号的现有知识.
作者讨论了将电动汽车研究转化为临床实践的挑战和机会.

主要成果:

电动汽车作为预测化学疗法即将发生的心脏毒性的生物标志物具有显著的前景.
电动汽车有可能被开发为治疗剂,以保护心脏免受化疗损伤.
EV种群的异质性和动态细胞状态使治疗结果的预测变得复杂.

结论:

了解电动汽车货物和信号动态对于开发针对心脏毒性的精确策略至关重要.
为了安全有效的临床应用,需要对EV异质性和短暂的毒性暴露进行进一步的研究.
电动汽车是提高抗癌治疗的安全性和有效性的有希望的途径.

关键词:

癌症癌症癌症癌症癌症心脏保护心脏保护心脏有毒性心脏有毒性化疗化疗是一种化学疗法.德克索鲁比辛 (doxorubicin) 是一种药物.细胞外囊泡中的细胞外囊泡.准确预防的准确预防.

更多相关视频

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

相关概念视频

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...